These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 943226)

  • 21. Complete regression of primary malignant melanoma.
    Emanuel PO; Mannion M; Phelps RG
    Am J Dermatopathol; 2008 Apr; 30(2):178-81. PubMed ID: 18360126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulation and homing of melanoma-reactive T cells to both cutaneous and visceral metastases after vaccination with monocyte-derived dendritic cells.
    Berger TG; Haendle I; Schrama D; Lüftl M; Bauer N; Pedersen LØ; Schuler-Thurner B; Hohenberger W; Straten Pt Pt; Schuler G; Becker JC
    Int J Cancer; 2004 Aug; 111(2):229-37. PubMed ID: 15197776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary invasive melanoma and basal cell carcinoma (collision tumor) with blue nevus-like cutaneous metastases.
    King R; Lyons J; Meyers AL; Googe PB; Page RN; Gupta VK
    J Cutan Pathol; 2007 Aug; 34(8):629-33. PubMed ID: 17640233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunization with irradiated tumour cells and specific lymphocyte cytotoxicity in malignant melanoma.
    Currie GA; Lejeune F; Fairley GH
    Br Med J; 1971 May; 2(5757):305-10. PubMed ID: 4930209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autonomous histopathological regression of primary tumours associated with specific immune responses to cancer antigens.
    Saleh FH; Crotty KA; Hersey P; Menzies SW; Rahman W
    J Pathol; 2003 Jul; 200(3):383-95. PubMed ID: 12845635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regression in thin malignant melanoma. Microscopic diagnosis and prognostic importance.
    Cooper PH; Wanebo HJ; Hagar RW
    Arch Dermatol; 1985 Sep; 121(9):1127-31. PubMed ID: 4037837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Completely regressed primary cutaneous malignant melanoma with metastases.
    Muniesa C; Ferreres JR; Moreno A; Marcoval J
    J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):327-8. PubMed ID: 18624860
    [No Abstract]   [Full Text] [Related]  

  • 28. Cytotoxicity reactions during immunotherapy of melanoma with neuraminidase altered autologous tumor cells.
    Miller EE; Rosato FE; Brown AS; Moskovitz A; Johnson J
    J Surg Oncol; 1976; 8(1):31-4. PubMed ID: 1249939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Completely regressed primary cutaneous malignant melanoma with nodal and/or visceral metastases: a report of 5 cases and assessment of the literature and diagnostic criteria.
    High WA; Stewart D; Wilbers CR; Cockerell CJ; Hoang MP; Fitzpatrick JE
    J Am Acad Dermatol; 2005 Jul; 53(1):89-100. PubMed ID: 15965428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A B7-1-transfected human melanoma line stimulates proliferation and cytotoxicity of autologous and allogeneic lymphocytes.
    Sulé-Suso J; Arienti F; Melani C; Colombo MP; Parmiani G
    Eur J Immunol; 1995 Oct; 25(10):2737-42. PubMed ID: 7589065
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metastatic melanoma with spontaneous regression, psoriasis and HLA-Cw6: case report and a hypothesis to explore.
    Pérez Ramírez S; Parra V; Avilés Izquierdo JA; Vicario JL; Martín M; Márquez-Rodas I
    Tumori; 2014; 100(4):144e-7e. PubMed ID: 25296606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunoperoxidase localization of lymphocyte subsets in the host response to melanoma and nevi.
    Kornstein MJ; Brooks JS; Elder DE
    Cancer Res; 1983 Jun; 43(6):2749-53. PubMed ID: 6342758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spontaneous regression of cutaneous head and neck melanoma: implications for the immunologic control of neoplasia.
    Dunn GP; Lewis JS; Sunwoo JB; Uppaluri R
    Head Neck; 2008 Feb; 30(2):267-72. PubMed ID: 17657794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell-mediated cytotoxicity for melanoma tumor cells: detection by a (3H) proline release assay.
    Saal JG; Rieber EP; Riethmüller G
    Scand J Immunol; 1976; 5(5):455-66. PubMed ID: 959779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spontaneous regression of melanoma may offer insight into cancer immunology.
    Printz C
    J Natl Cancer Inst; 2001 Jul; 93(14):1047-8. PubMed ID: 11459861
    [No Abstract]   [Full Text] [Related]  

  • 36. Growth and regression of cutaneous melanomas in Sinclair miniature swine.
    Oxenhandler RW; Berkelhammer J; Smith GD; Hook RR
    Am J Pathol; 1982 Dec; 109(3):259-69. PubMed ID: 6758603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spontaneous regression of metastatic melanoma - clinical evidence of the abscopal effect.
    Bramhall RJ; Mahady K; Peach AH
    Eur J Surg Oncol; 2014 Jan; 40(1):34-41. PubMed ID: 24139999
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spontaneous and antibody-dependent cellular cytotoxicity in melanoma patients and healthy control presons.
    Peter HH; Knoop F; Kalden JR
    Z Immunitatsforsch Exp Klin Immunol; 1976 Apr; 151(3):263-81. PubMed ID: 134545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Humoral and cell-mediated immune response in patients with malignant melanoma. I. In vitro lymphocyte reactivity to PHA and antigens following immunization.
    de Gast GC; The TH; Schraffordt Koops H; Huiges HA; Oldhoff J; Nieweg HO
    Cancer; 1975 Oct; 36(4):1289-97. PubMed ID: 1175127
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spontaneous partial regression of primary melanoma with death due to metastases.
    Saida T; Tsuchiya S
    Arch Dermatol; 1984 Nov; 120(11):1494-6. PubMed ID: 6497418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.